1. Home
  2. DWTX vs RHE Comparison

DWTX vs RHE Comparison

Compare DWTX & RHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DWTX
  • RHE
  • Stock Information
  • Founded
  • DWTX 2012
  • RHE 1988
  • Country
  • DWTX United States
  • RHE United States
  • Employees
  • DWTX N/A
  • RHE N/A
  • Industry
  • DWTX
  • RHE Real Estate
  • Sector
  • DWTX
  • RHE Real Estate
  • Exchange
  • DWTX NYSE
  • RHE Nasdaq
  • Market Cap
  • DWTX 3.1M
  • RHE 2.9M
  • IPO Year
  • DWTX N/A
  • RHE 2006
  • Fundamental
  • Price
  • DWTX $2.87
  • RHE $1.51
  • Analyst Decision
  • DWTX
  • RHE
  • Analyst Count
  • DWTX 0
  • RHE 0
  • Target Price
  • DWTX N/A
  • RHE N/A
  • AVG Volume (30 Days)
  • DWTX 24.3K
  • RHE 7.6K
  • Earning Date
  • DWTX 02-14-2025
  • RHE 11-19-2024
  • Dividend Yield
  • DWTX N/A
  • RHE N/A
  • EPS Growth
  • DWTX N/A
  • RHE N/A
  • EPS
  • DWTX N/A
  • RHE N/A
  • Revenue
  • DWTX N/A
  • RHE $15,753,000.00
  • Revenue This Year
  • DWTX N/A
  • RHE N/A
  • Revenue Next Year
  • DWTX N/A
  • RHE N/A
  • P/E Ratio
  • DWTX N/A
  • RHE N/A
  • Revenue Growth
  • DWTX N/A
  • RHE N/A
  • 52 Week Low
  • DWTX $1.62
  • RHE $1.13
  • 52 Week High
  • DWTX $23.50
  • RHE $3.08
  • Technical
  • Relative Strength Index (RSI)
  • DWTX N/A
  • RHE 42.16
  • Support Level
  • DWTX N/A
  • RHE $1.48
  • Resistance Level
  • DWTX N/A
  • RHE $1.57
  • Average True Range (ATR)
  • DWTX 0.00
  • RHE 0.07
  • MACD
  • DWTX 0.00
  • RHE -0.01
  • Stochastic Oscillator
  • DWTX 0.00
  • RHE 34.21

About DWTX DOGWOOD THERAPEUTICS INC

Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

About RHE Regional Health Properties Inc.

Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. It has two reportable segments real estate segment and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment. Its portfolio of properties is diversified across various states, with concentrations in Georgia and Ohio.

Share on Social Networks: